Potential cost to patient safety as NZ debates access to medicinal cannabis
- Written by Michelle Glass, Professor of Pharmacology, University of Otago

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. This unprecedented proposal is contained in the...
Read more: Potential cost to patient safety as NZ debates access to medicinal cannabis